Home > HP (current issue) > News and features / News Centre | Search

PJ Online homeHospital Pharmacist
Vol 12 No 2 p45
February 2005

Hospital Pharmacist back issues

News summary


Admissions increased by “at home” reviews

Emergency admissions to hospitals are increased by medication reviews carried out by pharmacists in patients’ homes, according to research published last month in the BMJ.

Researchers randomised 872 elderly patients who were discharged from hospital after an emergency admission with two or more prescribed drugs to receive two home visits by a pharmacist (intervention group) or their usual care (control group). Those in the intervention group went on to have 30 per cent more admissions to hospital and 43 per cent more home visits by GPs than those in the control group. Quality of life measures also decreased less in the control than the intervention group.

The researchers suggest three explanations. First, pharmacists may have enabled patients to understand their condition better, leading to patients being able to recognise warning signs earlier and seek help. This theory is supported by the smaller number (albeit not significantly) of deaths in the intervention group than the control group that was noted. Second, pharmacists might have encouraged patients to adhere to their medication regimens more than they otherwise would, thereby precipitating side-effects or drug interactions. Another possibility was that having pharmacists visit patients at home simply added to the complexity of care, increasing the confusion and anxiety of patients.

It is not clear from the paper whether the patients in either group received any advice about their medicines from hospital pharmacists during their emergency admissions.

The researchers conclude that: “… a growing body of evidence suggets that further research is necessary to elucidate the most effective form and detailed effects of medication review. The recommendation in the national service framework for older people that this should be widely introduced in primary care seems to lack a clear evidence base.”

Back to Top


©The Pharmaceutical Journal